Extrusion process for making compositions with poorly compressible therapeutic compounds

Details for Australian Patent Application No. 2011224098 (hide)

Owner Novartis AG

Inventors Vasanthavada, Madhav; Lakshman, Jay; Tong, Wei-Qin; Serajuddin, Abu T. M.; Joshi, Yatindra; Kowalski, James

Agent Davies Collison Cave

Pub. Number AU-A-2011224098

Parent 2010212296

Filing date 16 September 2011

Wipo publication date 6 October 2011

International Classifications

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 31/155 (2006.01) - Amidines (), e.g. guanidine (HNC(NH)NH), isourea (HNC(OH)NH), isothiourea (HNC(SH)NH)

Event Publications

29 September 2011 Complete Application Filed

6 October 2011 Application Open to Public Inspection

  Published as AU-A-2011224098

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011224099-Methods of using IL-1 antagonists to treat autoinflammatory disease

2011224097-Systems and methods for discriminating control solution from a physiological sample